AKT1 and breast carcinoma: These findings are consistent with a recent study in which the upregulation of circPRMT5 in breast cancer cells contributes to the aggressive phenotype by mediating the miR-509-3p/TCF7L2 axis to activate the PI3K/AKT pathway [32].